‘Subway’ map tracks journey of engineered stem cells

The differentiation of engineered stem cells may be imagined as a subway journey, where the genetic equivalents of missing a transfer or getting off at the wrong stop can take your stem cells far off course. In other words, your stem cells, when they finally detrain, may lack the characteristics you had in mind for them. But what if you had a map?

Such a map has, in fact, been created by scientists from Boston Children’s Hospital, the Wyss Institute, and Boston University. The map, called CellNet, is a computer algorithm, a network biology tool, that compares the gene regulatory networks (GRNs) of engineered cells with those of real-life counterpart cells in the body. With CellNet, researchers may assess:

  • the quality of induced pluripotent stem cells (iPS cells) made by reprogramming blood cells or skin cells;
  • the quality of specialized cells—such as liver, heart, muscle, brain or blood cells—made from either iPS cells or embryonic stem cells;
  • the quality of specialized cells made from other specialized cells (such as liver cells made directly from skin cells);
  • what specific improvements need to be made to the engineering process.

Read the full, original story: Mapping cell fate conversion via cellNet, a network biology tool

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-11-17-at-12.18.09-PM
Challenging glyphosate fear-mongering: Statewide Nebraska study finds no link between weedkiller use and non-Hodgkin lymphoma
BEMT Lotion for Freckled Skin
Burned by FDA bureaucracy: Why Americans waited decades for cancer-preventing sunscreen
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-11-17-at-12.56.22-PM
RFK Jr.’s CDC blocked measles risk alert for pregnant women; 112 contracted the disease, and one-quarter were hospitalized
Crisp Physicians’ Protest Sign Close-Up
‘He’s a disgrace’: Some newly-elected legislators and health groups call for RFK Jr. impeachment 
Nicotine Products on Gray Marble
Comparing vaping, nicotine patches and cigarettes: Not ‘safe vs. dangerous’  but ‘less harmful vs. more harmful’
ChatGPT-Image-Aug-18-2026-12_22_33-PM-2
‘The cure for measles is chicken soup and vitamin A’: Kennedy’s dangerous history of mocking vaccines
Split-Toned-Capitol-Healthcare-Rally
Viewpoint: Here’s how Congress can begin to reverse a two-year public health disinformation slide
Screenshot-2026-11-13-at-10.02.02-AM
Viewpoint: Why it’s such a big deal that under Trump-RFK Jr., the U.S. has lost its ‘measles-free’ status  
Screenshot-2026-11-17-at-11.04.14-AM
There are more than 6,000 genetic disorders. For the first time, gene editing is making some treatable. Are we ready?
Screenshot-2026-11-16-at-1.18.40-PM
‘Measles fiasco one of many healthcare failures’: Republican Sen. Bill Cassidy says it's time to fire RFK Jr.
Man in Green “Make America Healthy Again” Cap
Viewpoint: MAHA 2.0? Will the wellness grifters rescue RFK Jr.?
Screenshot-2026-11-12-at-11.22.35-AM
The science of an orgasm: It’s a lot more varied and complex than you might think
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.